Measure | Region of origin | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
USA | Australia and New Zealand | Western Europe | Middle East and North Africa | Pacific Islands | Latin America and Caribbean | Eastern Europe and Central Asia | East Asia | South Asia | Sub-Saharan Africa | Total | |
Incidence rate* | 5.5 | 6.9 | 13.3 | 27.4 | 48.0 | 49.7 | 104.2 | 160.8 | 198.5 | 292.8 | 137.0 |
Preimmigration screening (2008–2011) | |||||||||||
No. of preimmigration medicals† | 11 224 | 1 063 | 15 612 | 47 427 | 79 | 38 967 | 22 530 | 84 498 | 91 547 | 21 372 | 334 319 |
No. of cases (pulmonary) detected | 0 | 0 | 0 | 2 | 0 | 1 | 2 | 85 | 61 | 6 | 157 |
No. of preimmigration medicals per case (pulmonary) detected | NA | NA | NA | 23 714 | NA | 38 967 | 11 265 | 994 | 1 501 | 3 562 | 2 129 |
Postimmigration surveillance (2002–2011) | |||||||||||
No. of preimmigration medicals‡ | 28 501 | 2 605 | 35 886 | 113 093 | 303 | 97 646 | 86 960 | 236 740 | 283 016 | 59 625 | 944 375 |
No. of postimmigration surveillance referrals | 127 | 11 | 317 | 875 | 2 | 998 | 2 249 | 10 196 | 6 256 | 1 360 | 22 391 |
No. of preimmigration medicals per surveillance referral | 224.4 | 236.8 | 113.2 | 129.2 | 151.5 | 97.8 | 38.7 | 23.2 | 45.2 | 43.8 | 42.2 |
No. of patients who complied with surveillance | 91 | 8 | 172 | 490 | 0 | 653 | 1 098 | 6 315 | 3 724 | 836 | 13 387 |
No. of cases (all sites) detected within 2 yr of immigration | 0 | 0 | 0 | 4 | 0 | 11 | 16 | 156 | 214 | 101 | 502 |
No. of cases (all sites) potentially detectable§ through surveillance | 0 | 0 | 0 | 3 | 0 | 2 | 5 | 67 | 74 | 17 | 168 |
No. of cases (all sites) actually detected through surveillance | 0 | 0 | 0 | 3 | 0 | 2 | 4 | 46 | 38 | 9 | 102 |
No. of preimmigration medicals per potentially detectable§ case | NA | NA | NA | 37 698 | NA | 48 823 | 17 392 | 3 533 | 3 825 | 3 507 | 5 621 |
No. of preimmigration medicals per actually detected case | NA | NA | NA | 37 698 | NA | 48 823 | 21 740 | 5 147 | 7 448 | 6 625 | 9 259 |
No. of postimmigration surveillance referrals per potentially detectable§ case | NA | NA | NA | 291.7 | NA | 499.0 | 449.8 | 152.2 | 84.5 | 80.0 | 133.3 |
No. of postimmigration surveillance referrals per actually detected case | NA | NA | NA | 291.7 | NA | 499.0 | 562.3 | 221.7 | 164.6 | 151.1 | 219.5 |
Note: NA = undefined values where no cases were detected.
↵* Calculated by weighting the World Health Organization–reported national tuberculosis incidence rate for each birth country in the year of immigration by the corresponding number of immigrants.
↵† Outcome data for preimmigration screening reflect the period between 2008 and 2011 (n = 334 319 medicals given to people who became permanent residents). Given the purpose of preimmigration screening to detect communicable diseases, only pulmonary tuberculosis cases were reported.
↵‡ Outcome data for postimmigration surveillance reflect the period between 2002 and 2011 (n = 944 375 medicals given to people who became permanent residents).
↵§ Potentially detectable tuberculosis was defined as active disease developing at any site within 2 years of immigration among people who were referred to postimmigration surveillance.